Burns
Volume 36, Issue 3 , Pages 305-321 , May 2010

Biological background of dermal substitutes

  • Vincent C. van der Veen

      Affiliations

    • Association of Dutch Burn Centers, Beverwijk, The Netherlands
    • ,
  • Martijn B.A. van der Wal

      Affiliations

    • Association of Dutch Burn Centers, Beverwijk, The Netherlands
    • Burn Center, Red Cross Hospital, Beverwijk, The Netherlands
    • ,
  • Michiel C.E. van Leeuwen

      Affiliations

    • Association of Dutch Burn Centers, Beverwijk, The Netherlands
    • Burn Center, Red Cross Hospital, Beverwijk, The Netherlands
    • ,
  • Magda M.W. Ulrich

      Affiliations

    • Association of Dutch Burn Centers, Beverwijk, The Netherlands
    • Department of Plastic, Reconstructive and Hand Surgery, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Esther Middelkoop

      Affiliations

    • Association of Dutch Burn Centers, Beverwijk, The Netherlands
    • Burn Center, Red Cross Hospital, Beverwijk, The Netherlands
    • Department of Plastic, Reconstructive and Hand Surgery, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author at: Association of Dutch Burn Centers, Red Cross Hospital, Postbus 1074, 1940 EB Beverwijk, The Netherlands. Tel.: +31 251265283; fax: +31 251264948.

,Accepted 13 July 2009.

References 

  1. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol. 1993;100(May (5)):721–725
  2. Ehrlich HP. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Am J Surg. 2004;187(May (5A)):29S–33S
  3. Teepe RG, Kreis RW, Koebrugge EJ, Kempenaar JA, Vloemans AF, Hermans RP, et al. The use of cultured autologous epidermis in the treatment of extensive burn wounds. J Trauma. 1990;30(March (3)):269–275
  4. Hansbrough JF, Franco ES. Skin replacements. Clin Plast Surg. 1998 Jul;25(3):407–423
  5. Gallico GG, O’Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med. 1984;311(August (7)):448–451
  6. Eldad A, Burt A, Clarke JA, Gusterson B. Cultured epithelium as a skin substitute. Burns Incl Therm Inj. 1987 Jun;13(3):173–180
  7. Rue LW, Cioffi WG, McManus WF, Pruitt BA. Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J Trauma. 1993;34(May (5)):662–667[discussion 7–8]
  8. Herzog SR, Meyer A, Woodley D, Peterson HD. Wound coverage with cultured autologous keratinocytes: use after burn wound excision, including biopsy follow up. J Trauma. 1988;28(February (2)):195–198
  9. Clugston PA, Snelling CF, Macdonald IB, Maledy HL, Boyle JC, Germann E, et al. Cultured epithelial autografts: three years of clinical experience with eighteen patients. J Burn Care Rehabil. 1991;12(November–December (6)):533–539
  10. Desai MH, Mlakar JM, McCauley RL, Abdullah KM, Rutan RL, Waymack JP, et al. Lack of long-term durability of cultured keratinocyte burn-wound coverage: a case report. J Burn Care Rehabil. 1991;12(November–December (6)):540–545
  11. Williamson JS, Snelling CF, Clugston P, Macdonald IB, Germann E. Cultured epithelial autograft: five years of clinical experience with twenty-eight patients. J Trauma. 1995;39(August (2)):309–319
  12. Rennekampff HO, Kiessig V, Hansbrough JF. Current concepts in the development of cultured skin replacements. J Surg Res. 1996;62(May (2)):288–295
  13. Hernon CADR, Freedlander E, Short R, Haddow DB, Brotherston M, MacNeil S. Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen Med. 2006;1(6):809–821
  14. Hernon CA, Harrison CA, Thornton DJ, MacNeil S. Enhancement of keratinocyte performance in the production of tissue-engineered skin using a low-calcium medium. Wound Repair Regen. 2007;15(September–October (5)):718–726
  15. Coolen NA, Verkerk M, Reijnen L, Vlig M, van den Bogaerdt AJ, Breetveld M, et al. Culture of keratinocytes for transplantation without the need of feeder layer cells. Cell Transpl. 2007;16(6):649–661
  16. Woodley DT, Peterson HD, Herzog SR, Stricklin GP, Burgeson RE, Briggaman RA, et al. Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils. JAMA. 1988;259(May (17)):2566–2571
  17. Margolis DJ. The swings and roundabouts of randomized controlled studies in wound healing. Int J Low Extrem Wounds. 2004;3(March (1)):4–6
  18. Wainwright D, Madden M, Luterman A, Hunt J, Monafo W, Heimbach D, et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil. 1996;17(March–April (2)):124–136
  19. Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP. Randomized clinical trial comparing OASIS wound matrix to Regranex gel for diabetic ulcers. Adv Skin Wound Care. 2005;18(June (5 Pt 1)):258–266
  20. Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg. 1988;208(September (3)):313–320
  21. van Zuijlen PP, Vloemans JF, van Trier AJ, Suijker MH, van Unen E, Groenevelt F, et al. Dermal substitution in acute burns and reconstructive surgery: a subjective and objective long-term follow-up. Plastic Reconstruct Surg. 2001;108(December (7)):1938–1946
  22. Hansbrough JF, Mozingo DW, Kealey GP, Davis M, Gidner A, Gentzkow GD. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil. 1997;18(January–February (1 Pt 1)):43–51
  23. Van Dorp AG, Verhoeven MC, Koerten HK, Van Der Nat-Van Der Meij TH, Van Blitterswijk CA, Ponec M. Dermal regeneration in full-thickness wounds in Yucatan miniature pigs using a biodegradable copolymer. Wound Repair Regen. 1998;6(November–December (6)):556–568
  24. Burke JF, Yannas IV, Quinby WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg. 1981;194(October (4)):413–428
  25. Groos N, Guillot M, Zilliox R, Braye FM. Use of an artificial dermis (Integra) for the reconstruction of extensive burn scars in children. About 22 grafts. Eur J Pediatr Surg. 2005;15(June (3)):187–192
  26. van Zuijlen PP, van Trier AJ, Vloemans JF, Groenevelt F, Kreis RW, Middelkoop E. Graft survival and effectiveness of dermal substitution in burns and reconstructive surgery in a one-stage grafting model. Plastic Reconstruct Surg. 2000 Sep;106(3):615–623
  27. Lineen E, Namias N. Biologic dressing in burns. J Craniofacial Surg. 2008;19(July (4)):923–928
  28. Whitaker IS, Prowse S, Potokar TS. A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon. Annal Plastic Surg. 2008;60(March (3)):333–337
  29. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res. 1980;14(March (2)):107–132
  30. McKegney M, Taggart I, Grant MH. The influence of crosslinking agents and diamines on the pore size, morphology and the biological stability of collagen sponges and their effect on cell penetration through the sponge matrix. J Mater Sci Mater Med. 2001;12(September (9)):833–844
  31. Nishi C, Nakajima N, Ikada Y. In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification. J Biomed Mater Res. 1995;29(July (7)):829–834
  32. Dagalakis N, Flink J, Stasikelis P, Burke JF, Yannas IV. Design of an artificial skin. Part III. Control of pore structure. J Biomed Mater Res. 1980;14(July (4)):511–528
  33. Suzuki S, Matsuda K, Isshiki N, Tamada Y, Ikada Y. Experimental study of a newly developed bilayer artificial skin. Biomaterials. 1990;11(July (5)):356–360
  34. Wang H, Pieper J, Peters F, van Blitterswijk CA, Lamme EN. Synthetic scaffold morphology controls human dermal connective tissue formation. J Biomed Mater Res. 2005;74(September (4)):523–532
  35. Lamme EN, van Leeuwen RT, Mekkes JR, Middelkoop E. Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen. 2002;10(May–June (3)):152–160
  36. Yannas IV, Burke JF. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res. 1980;14(January (1)):65–81
  37. Hermans MH. Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns. Burns Incl Therm Inj. 1989;15(February (1)):57–59
  38. Richters CD, Hoekstra MJ, du Pont JS, Kreis RW, Kamperdijk EW. Immunology of skin transplantation. Clin Dermatol. 2005;23(July–August (4)):338–342
  39. Richters CD, Pirayesh A, Hoeksema H, Kamperdijk EW, Kreis RW, Dutrieux RP, et al. Development of a dermal matrix from glycerol preserved allogeneic skin. Cell Tissue Bank. 2008;9(December (4)):309–315
  40. Ghosh MM, Boyce S, Layton C, Freedlander E, Mac Neil S. A comparison of methodologies for the preparation of human epidermal-dermal composites. Annal Plastic Surg. 1997;39(October (4)):390–404
  41. Ralston DR, Layton C, Dalley AJ, Boyce SG, Freedlander E, Mac Neil S. The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro. Br J Dermatol. 1999;140(April (4)):605–615
  42. Krejci NC, Cuono CB, Langdon RC, McGuire J. In vitro reconstitution of skin: fibroblasts facilitate keratinocyte growth and differentiation on acellular reticular dermis. J Invest Dermatol. 1991;97(November (5)):843–848
  43. Griffey ES, Liveley SA. Production of an in vitro reconstituted skin using human neonatal foreskin keratinocytes (HFK) in combination with the dermal substrate AlloDerm. In: Presented at the congress on in vitro biology. May 20–24. 1995;
  44. Livesey SA, Herndon DN, Hollyoak MA, Atkinson YH, Nag A. Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis. Transplantation. 1995;60(July (1)):1–9
  45. Sahota PS, Burn JL, Heaton M, Freedlander E, Suvarna SK, Brown NJ, et al. Development of a reconstructed human skin model for angiogenesis. Wound Repair Regen. 2003;11(July–August (4)):275–284
  46. Branski LK, Herndon DN, Pereira C, Mlcak RP, Celis MM, Lee JO, et al. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med. 2007;35(November (11)):2615–2623
  47. Peck MD, Kessler M, Meyer AA, Bonham Morris PA. A trial of the effectiveness of artificial dermis in the treatment of patients with burns greater than 45% total body surface area. J Trauma. 2002;52(May (5)):971–978
  48. Haslik W, Kamolz LP, Manna F, Hladik M, Rath T, Frey M. Management of full-thickness skin defects in the hand and wrist region: first long-term experiences with the dermal matrix Matriderm((R)). J Plast Reconstr Aesthet Surg. 2008;
  49. DeLustro F, Dasch J, Keefe J, Ellingsworth L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clinical orthopaedics and related research. 1990;(November (260)):263–279
  50. Lynn AK, Yannas IV, Bonfield W. Antigenicity and immunogenicity of collagen. J Biomed Mater Res B: Appl Biomater. 2004;71(November (2)):343–354
  51. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001;305(September (3)):285–298
  52. De Vries HJ, Mekkes JR, Middelkoop E, Hinrichs WL, Wildevuur CR, Westerhof W. Dermal substitutes for full-thickness wounds in a one-stage grafting model. Wound Repair Regen. 1993;1(October (4)):244–252
  53. Middelkoop E, de Vries HJ, Ruuls L, Everts V, Wildevuur CH, Westerhof W. Adherence, proliferation and collagen turnover by human fibroblasts seeded into different types of collagen sponges. Cell Tissue Res. 1995;280(May (2)):447–453
  54. Tomasek JJ, Haaksma CJ, Eddy RJ, Vaughan MB. Fibroblast contraction occurs on release of tension in attached collagen lattices: dependency on an organized actin cytoskeleton and serum. Anat Rec. 1992;232(March (3)):359–368
  55. Ehrlich HP, Sun B, Kainth KS, Kromah F. Elucidating the mechanism of wound contraction: rapid versus sustained myosin ATPase activity in attached-delayed-released compared with free-floating fibroblast-populated collagen lattices. Wound Repair Regen. 2006;14(September–October (5)):625–632
  56. Hinz B. Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol. 2006;85(April (3–4)):175–181
  57. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005;13(January–February (1)):7–12
  58. Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J. 2007;21(October (12)):3250–3261
  59. Emonard H, Hornebeck W. Binding of 92kDa and 72kDa progelatinases to insoluble elastin modulates their proteolytic activation. Biol Chem. 1997;378(March–April (3–4)):265–271
  60. de Vries HJ, Middelkoop E, Mekkes JR, Dutrieux RP, Wildevuur CH, Westerhof H. Dermal regeneration in native non-cross-linked collagen sponges with different extracellular matrix molecules. Wound Repair Regen. 1994;2(January (1)):37–47
  61. Stern R, McPherson M, Longaker MT. Histologic study of artificial skin used in the treatment of full-thickness thermal injury. J Burn Care Rehabil. 1990;11(January–February (1)):7–13
  62. Moiemen NS, Staiano JJ, Ojeh NO, Thway Y, Frame JD. Reconstructive surgery with a dermal regeneration template: clinical and histologic study. Plastic Reconstruct Surg. 2001;108(July (1)):93–103
  63. Lamme EN, de Vries HJ, van Veen H, Gabbiani G, Westerhof W, Middelkoop E. Extracellular matrix characterization during healing of full-thickness wounds treated with a collagen/elastin dermal substitute shows improved skin regeneration in pigs. J Histochem Cytochem. 1996;44(November (11)):1311–1322
  64. Hahnenberger R, Jakobson AM. Antiangiogenic effect of sulphated and nonsulphated glycosaminoglycans and polysaccharides in the chick embryo chorioallantoic membrane. Glycoconj J. 1991;8(August (4)):350–353
  65. Luo H, Xu J, Yu X. Isolation and bioactivity of an angiogenesis inhibitor extracted from the cartilage of Dasyatis akajei. Asia Pac J Clin Nutr. 2007;16(Suppl. 1):286–289
  66. Robinet A, Fahem A, Cauchard JH, Huet E, Vincent L, Lorimier S, et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci. 2005;118(January (Pt 2)):343–356
  67. Tummalapalli CM, Tyagi SC. Responses of vascular smooth muscle cell to extracellular matrix degradation. J Cell Biochem. 1999;75(December (3)):515–527
  68. Blackwood KA, McKean R, Canton I, Freeman CO, Franklin KL, Cole D, et al. Development of biodegradable electrospun scaffolds for dermal replacement. Biomaterials. 2008;29(July (21)):3091–3104
  69. Powell HM, Boyce ST. Engineered human skin fabricated using electrospun collagen-PCL blends: morphogenesis and mechanical properties. Tissue Eng Part A. 2009;15(8):2177–2187
  70. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell–matrix adhesions to the third dimension. Science. 2001;294(November (5547)):1708–1712
  71. Green JA, Yamada KM. Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliv Rev. 2007;59(November (13)):1293–1298
  72. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials. 2003;24(November (24)):4353–4364
  73. Hersel U, Dahmen C, Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003;24(November (24)):4385–4415
  74. Hern DL, Hubbell JA. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res. 1998;39(February (2)):266–276
  75. Zhou M, Smith AM, Das AK, Hodson NW, Collins RF, Ulijn RV, et al. Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials. 2009;30(May (13)):2523–2530
  76. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB, et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA. 2003;100(April (9)):5413–5418
  77. Raeber GP, Lutolf MP, Hubbell JA. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J. 2005;89(August (2)):1374–1388
  78. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003;160(January (2)):267–277
  79. van Wachem PB, van Luyn MJ, Nieuwenhuis P, Koerten HK, Olde Damink L, Ten Hoopen H, et al. In vivo degradation of processed dermal sheep collagen evaluated with transmission electron microscopy. Biomaterials. 1991;12(March (2)):215–223
  80. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(April (2)):86–100
  81. Coolen NA, Vlig M, van den Bogaerdt AJ, Middelkoop E, Ulrich MM. Development of an in vitro burn wound model. Wound Repair Regen. 2008;16(July–August (4)):559–567
  82. Paul Ehrlich H, Sun B, Kainth KS, Kromah F. Elucidating the mechanism of wound contraction: rapid versus sustained myosin ATPase activity in attached-delayed-released compared with free-floating fibroblast-populated collagen lattices. Wound Repair Regen. 2006;14(September–October (5)):625–632
  83. Boelsma E, Verhoeven MC, Ponec M. Reconstruction of a human skin equivalent using a spontaneously transformed keratinocyte cell line (HaCaT). J Invest Dermatol. 1999;112(April (4)):489–498
  84. Tjabringa G, Bergers M, van Rens D, de Boer R, Lamme E, Schalkwijk J. Development and validation of human psoriatic skin equivalents. Am J Pathol. 2008;173(September (3)):815–823
  85. Ghahary A, Ghaffari A. Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar. Wound Repair Regen. 2007;15(September–October (Suppl. 1)):S46–S53
  86. El-Ghalbzouri A, Gibbs S, Lamme E, Van Blitterswijk CA, Ponec M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol. 2002;147(August (2)):230–243
  87. El Ghalbzouri A, Lamme E, Ponec M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res. 2002;310(November (2)):189–199
  88. Aoki S, Toda S, Ando T, Sugihara H. Bone marrow stromal cells, preadipocytes, and dermal fibroblasts promote epidermal regeneration in their distinctive fashions. Mol Biol Cell. 2004;15(October (10)):4647–4657
  89. Davidson JM. Animal models for wound repair. Arch Dermatol Res. 1998;290(July (Suppl.)):S1–S11
  90. Kyriakides TR, Bornstein P. Matricellular proteins as modulators of wound healing and the foreign body response. Thrombos Haemostas. 2003;90(December (6)):986–992
  91. Beumer GJ, van Blitterswijk CA, Ponec M. Degradative behaviour of polymeric matrices in (sub)dermal and muscle tissue of the rat: a quantitative study. Biomaterials. 1994;15(June (7)):551–559
  92. Druecke D, Lamme EN, Hermann S, Pieper J, May PS, Steinau HU, et al. Modulation of scar tissue formation using different dermal regeneration templates in the treatment of experimental full-thickness wounds. Wound Repair Regen. 2004;12(September–October (5)):518–527
  93. Middelkoop E, van den Bogaerdt AJ, Lamme EN, Hoekstra MJ, Brandsma K, Ulrich MM. Porcine wound models for skin substitution and burn treatment. Biomaterials. 2004;25(April (9)):1559–1567
  94. Lindblad WJ. Considerations for selecting the correct animal model for dermal wound-healing studies. J Biomater Sci. 2008;19(8):1087–1096
  95. Ehrlich HP, Needle AL. Wound healing in tight-skin mice: delayed closure of excised wounds. Plastic Reconstruct Surg. 1983;72(August (2)):190–198
  96. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. 2004;12(July–August (4)):485–492
  97. Sullivan TP, Eaglstein WH, Davis SC, Mertz P. The pig as a model for human wound healing. Wound Repair Regen. 2001;9(March–April (2)):66–76
  98. Gross J, Farinelli W, Sadow P, Anderson R, Bruns R. On the mechanism of skin wound “contraction”: a granulation tissue “knockout” with a normal phenotype. Proc Natl Acad Sci USA. 1995;92(June (13)):5982–5986
  99. Hinrichsen N, Birk-Sorensen L, Gottrup F, Hjortdal V. Wound contraction in an experimental porcine model. Scand J Plastic Reconstruct Surg Hand Surg Nordisk plastikkirurgisk forening [and] Nordisk klubb for handkirurgi. 1998;32(September (3)):243–248
  100. Reid MJ, Currie LJ, James SE, Sharpe JR. Effect of artificial dermal substitute, cultured keratinocytes and split thickness skin graft on wound contraction. Wound Repair Regen. 2007;15(November–December (6)):889–896
  101. Varma MJ, Breuls RG, Schouten TE, Jurgens WJ, Bontkes HJ, Schuurhuis GJ, et al. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Develop. 2007;16(February (1)):91–104
  102. van den Bogaerdt AJ, van Zuijlen PP, van Galen M, Lamme EN, Middelkoop E. The suitability of cells from different tissues for use in tissue-engineered skin substitutes. Arch Dermatol Res. 2002;294(May (3)):135–142
  103. Ramos ML, Gragnani A, Ferreira LM. Is there an ideal animal model to study hypertrophic scarring?. J Burn Care Res. 2008;29(March–April (2)):363–368
  104. Bello YM, Falabella AF, Eaglstein WH. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol. 2001;2(5):305–313
  105. Jones I, Currie L, Martin R. A guide to biological skin substitutes. Br J Plast Surg. 2002;55(April (3)):185–193
  106. Ruszczak Z. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev. 2003;55(November (12)):1595–1611
  107. Clark RA, Ghosh K, Tonnesen MG. Tissue engineering for cutaneous wounds. J Invest Dermatol. 2007;127(May (5)):1018–1029
  108. Pham C, Greenwood J, Cleland H, Woodruff P, Maddern G. Bioengineered skin substitutes for the management of burns: a systematic review. Burns. 2007;33(December (8)):946–957
  109. Boyce ST, Warden GD. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg. 2002;183(April (4)):445–456
  110. Powers PS, Sarkar S, Goldgof DB, Cruse CW, Tsap LV. Scar assessment: current problems and future solutions. J Burn Care Rehabil. 1999;20(January–February (1 Pt 1)):54–60[discussion 53]
  111. Bond JS, Duncan JA, Sattar A, Boanas A, Mason T, O’Kane S, et al. Maturation of the human scar: an observational study. Plastic Reconstruct Surg. 2008;121(May (5)):1650–1658
  112. van Zuijlen PP, Angeles AP, Kreis RW, Bos KE, Middelkoop E. Scar assessment tools: implications for current research. Plastic Reconstruct Surg. 2002;109(March (3)):1108–1122
  113. Sullivan T, Smith J, Kermode J, McIver E, Courtemanche DJ. Rating the burn scar. J Burn Care Rehabil. 1990;11(May–June (3)):256–260
  114. Beausang E, Floyd H, Dunn KW, Orton CI, Ferguson MW. A new quantitative scale for clinical scar assessment. Plastic Reconstruct Surg. 1998;102(November (6)):1954–1961
  115. Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plastic Reconstruct Surg. 2004;113(June (7)):1960–1965[discussion 6–7]
  116. van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plastic Reconstruct Surg. 2005;116(August (2)):514–522
  117. Draaijers LJ, Tempelman FR, Botman YA, Kreis RW, Middelkoop E, van Zuijlen PP. Colour evaluation in scars: tristimulus colorimeter, narrow-band simple reflectance meter or subjective evaluation?. Burns. 2004;30(March (2)):103–107
  118. Oliveira GV, Chinkes D, Mitchell C, Oliveras G, Hawkins HK, Herndon DN. Objective assessment of burn scar vascularity, erythema, pliability, thickness, and planimetry. Dermatol Surg. 2005;31(January (1)):48–58
  119. Nedelec B, Correa JA, Rachelska G, Armour A, LaSalle L. Quantitative measurement of hypertrophic scar: intrarater reliability, sensitivity, and specificity. J Burn Care Res. 2008;29(May–June (3)):489–500
  120. Nedelec B, Correa JA, Rachelska G, Armour A, LaSalle L. Quantitative measurement of hypertrophic scar: interrater reliability and concurrent validity. J Burn Care Res. 2008;29(May–June (3)):501–511
  121. Lau JC, Li-Tsang CW, Zheng YP. Application of tissue ultrasound palpation system (TUPS) in objective scar evaluation. Burns. 2005;31(June (4)):445–452
  122. Du YC, Lin CM, Chen YF, Chen CL, Chen T. Implementation of a burn scar assessment system by ultrasound techniques. Conf Proc IEEE Eng Med Biol Soc. 2006;1:2328–2331
  123. Friedman PM, Skover GR, Payonk G, Kauvar AN, Geronemus RG. 3D in-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology. Dermatol Surg. 2002;28(March (3)):199–204
  124. Lagarde JM, Rouvrais C, Black D, Diridollou S, Gall Y. Skin topography measurement by interference fringe projection: a technical validation. Skin Res Technol. 2001;7(May (2)):112–121
  125. Saur R, Schramm U, Steinhoff R, Wolff HH. Structure analysis of the skin surface using computer-assisted laser profilometry. New method for the quantitative assessment of roughness structure of the skin. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1991;42(August (8)):499–506
  126. Fong SS, Hung LK, Cheng JC. The cutometer and ultrasonography in the assessment of postburn hypertrophic scar—a preliminary study. Burns. 1997;23(March (Suppl. 1)):S12–S18
  127. Draaijers LJ, Botman YA, Tempelman FR, Kreis RW, Middelkoop E, van Zuijlen PP. Skin elasticity meter or subjective evaluation in scars: a reliability assessment. Burns. 2004;30(March (2)):109–114
  128. Boyce ST, Supp AP, Wickett RR, Hoath SB, Warden GD. Assessment with the dermal torque meter of skin pliability after treatment of burns with cultured skin substitutes. J Burn Care Rehabil. 2000;21(January–February (1 Pt 1)):55–63
  129. Wysocki AB. Wound measurement. Int J Dermatol. 1996;35(February (2)):82–91
  130. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns. 1995;21(June (4)):243–248
  131. Jung SN, Chung JW, Yim YM, Kwon H. One-stage skin grafting of the exposed skull with acellular human dermis (AlloDerm). J Craniofacial Surg. 2008;19(November (6)):1660–1662
  132. Barret JP, Dziewulski P, McCauley RL, Herndon DN, Desai MH. Dural reconstruction of a class IV calvarial burn with decellularized human dermis. Burns. 1999;25(August (5)):459–462
  133. Lattari V, Jones LM, Varcelotti JR, Latenser BA, Sherman HF, Barrette RR. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil. 1997;18(March–April (2)):147–155
  134. de Moya MA, Dunham M, Inaba K, Bahouth H, Alam HB, Sultan B, et al. Long-term outcome of acellular dermal matrix when used for large traumatic open abdomen. J Trauma. 2008;65(August (2)):349–353
  135. Becker S, Saint-Cyr M, Wong C, Dauwe P, Nagarkar P, Thornton JF, et al. AlloDerm versus DermaMatrix in immediate expander-based breast reconstruction: a preliminary comparison of complication profiles and material compliance. Plastic Reconstruct Surg. 2009;123(January (1)):1–6[discussion 107–8]
  136. Barber FA, Herbert MA, Coons DA. Tendon augmentation grafts: biomechanical failure loads and failure patterns. Arthroscopy. 2006;22(May (5)):534–538
  137. Brigido SA, Boc SF, Lopez RC. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study. Orthopedics. 2004;27(January (Suppl. 1)):s145–s149
  138. Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J. 2006;3(September (3)):181–187
  139. Martin BR, Sangalang M, Wu S, Armstrong DG. Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience. Int Wound J. 2005;2(June (2)):161–165
  140. Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005;41(May (5)):837–843
  141. Romanelli M, Dini V, Bertone M, Barbanera S, Brilli C. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J. 2007;4(March (1)):3–7
  142. Benbow M. Oasis: an innovative alternative dressing for chronic wounds. Br J Nurs. 2002;10(22):1489–1492
  143. Gibbs S, van den Hoogenband HM, Kirtschig G, Richters CD, Spiekstra SW, Breetveld M, et al. Autologous full-thickness skin substitute for healing chronic wounds. Br J Dermatol. 2006;155(August (2)):267–274
  144. Waymack P, Duff RG, Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group. Burns. 2000;26(November (7)):609–619
  145. Parenteau NL, Nolte CM, Bilbo P, Rosenberg M, Wilkins LM, Johnson EW, et al. Epidermis generated in vitro: practical considerations and applications. J Cell Biochem. 1991;45(March (3)):245–251
  146. Donohue KG, Carson P, Iriondo M, Zhou L, Saap L, Gibson K, et al. Safety and efficacy of a bilayered skin construct in full-thickness surgical wounds. J Dermatol. 2005;32(August (8)):626–631
  147. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7(July–August (4)):201–207
  148. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol. 1998;134(March (3)):293–300
  149. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24(February (2)):290–295
  150. Muhart M, McFalls S, Kirsner RS, Elgart GW, Kerdel F, Sabolinski ML, et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites. Arch Dermatol. 1999;135(August (8)):913–918
  151. Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a ‘smart material’ for healing wounds: experience in venous ulcers. Biomaterials. 1996;17(February (3)):311–320
  152. Eaglstein WH, Alvarez OM, Auletta M, Leffel D, Rogers GS, Zitelli JA, et al. Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol Surg. 1999;25(March (3)):195–201
  153. Shealy FG, DeLoach ED. Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting. Adv Skin Wound Care. 2006;19(July–August (6)):310–322
  154. Gohari S, Gambla C, Healey M, Spaulding G, Gordon KB, Swan J, et al. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol Surg. 2002;28(December (12)):1107–1114[discussion 14]
  155. Falabella AF, Schachner LA, Valencia IC, Eaglstein WH. The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol. 1999;135(October (10)):1219–1222
  156. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol. 2000;136(October (10)):1225–1230
  157. Martin LK, Kirsner RS. Ulcers caused by bullous morphea treated with tissue-engineered skin. Int J Dermatol. 2003;42(May (5)):402–404
  158. Ozerdem OR, Wolfe SA, Marshall D. Use of skin substitutes in pediatric patients. J Craniofacial Surg. 2003;14(July (4)):517–520
  159. Stark HJ, Boehnke K, Mirancea N, Willhauck MJ, Pavesio A, Fusenig NE, et al. Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J Invest Dermat Sympos Proc/Soc Invest Dermat Inc. 2006;11(September (1)):93–105
  160. Zacchi V, Soranzo C, Cortivo R, Radice M, Brun P, Abatangelo G. In vitro engineering of human skin-like tissue. J Biomed Mater Res. 1998;40(May (2)):187–194
  161. Tamisani AM. The use of Hyalomatrix in deep paediatric burns. Annal Burns Fire Disasters. 2004;XVII(December):4
  162. Gravante G, Delogu D, Giordan N, Morano G, Montone A, Esposito G. The use of Hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res. 2007;28(March–April (2)):269–274
  163. Heimbach DM, Warden GD, Luterman A, Jordan MH, Ozobia N, Ryan CM, et al. Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil. 2003;24(January–February (1)):42–48
  164. Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg. 2001;54(December (8)):659–664
  165. Campitiello E, Della Corte A, Fattopace A, D’Acunzi D, Canonico S. The use of artificial dermis in the treatment of chronic and acute wounds: regeneration of dermis and wound healing. Acta Biomed. 2005;76(Suppl. 1):69–71
  166. Verolino P, Casoli V, Masia D, Delia G, Isacu C, Castede JC. A skin substitute (Integra) in a successful delayed reconstruction of a severe injured hand. Burns. 2008;34(March (2)):284–287
  167. Ryssel H, Gazyakan E, Germann G, Ohlbauer M. The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns—a pilot study. Burns. 2008;34(February (1)):93–97
  168. Haslik W, Kamolz LP, Nathschlager G, Andel H, Meissl G, Frey M. First experiences with the collagen–elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns. 2007;33(May (3)):364–368
  169. Still J, Glat P, Silverstein P, Griswold J, Mozingo D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns. 2003;29(December (8)):837–841
  170. Eisenberg M, Llewelyn D. Surgical management of hands in children with recessive dystrophic epidermolysis bullosa: use of allogeneic composite cultured skin grafts. Br J Plast Surg. 1998;51(December (8)):608–613
  171. Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel RL, Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials. 1991;12(March (2)):243–248
  172. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care. 1996;19(April (4)):350–354
  173. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs. 1997;21(November (11)):1203–1210
  174. Beumer GJ, van Blitterswijk CA, Bakker D, Ponec M. A new biodegradable matrix as part of a cell seeded skin substitute for the treatment of deep skin defects: a physico-chemical characterisation. Clin Mater. 1993;14(1):21–27

PII: S0305-4179(09)00486-0

doi: 10.1016/j.burns.2009.07.012

Burns
Volume 36, Issue 3 , Pages 305-321 , May 2010

Article Tools

* Image Usage & Resolution